Virginia Bastian

Dr. Virginia Bastian (Global Head of Talent & Development, Suitability at Deutsche Bank) is a guest on the Transformation Leaders Podcast hosted by René Esteban (Founder, CEO of FocusFirst). Both talk about how leaders can create a culture of inclusivity and diversity within their team or organization, and effectively address issues of discrimination or bias if they arise.

About Dr. Virginia Bastian (LinkedIn): Virginia has worked across different industries as a consultant, held various managerial roles at Nestlé, and was responsible for big transformational projects, people and organisational development, and strategic HR work. In 2021 she joined Deutsche Bank as Global Head of Talent & Development and Suitability. She is passionate about driving change and positively impacting people and organisations and gets her energy from working with diverse people to shape the future.

About René Esteban (LinkedIn): René Esteban is Founder and CEO of FocusFirst. As a former senior leader in a Fortune 500, he found that too many transformation projects take too long, waste money, and annoy key stakeholders – and that there must be a way to accelerate business transformations sustainably. Today, this belief unites an international FocusFirst team consisting of former top executives and subject matter experts. He is an international keynote speaker, author and senior advisor for top executives to achieve challenging goals and accelerate complex transformations.

About FocusFirst (LinkedIn): FocusFirst is a boutique consulting firm for transformation & strategic change projects. We are the specialised firm in the industry that combines former top executives and an award-winning method to accelerate transformations. This unique “double helix” of capabilities equips us to help our customers deliver results faster against demanding business goals. Executives work with FocusFirst to develop organisations, structure & accelerate transformations. FocusFirst works with leading Fortune 500 companies such as Merck, Novartis, E.ON, BASF, as well as established mid-sized companies.

Special edition in English.